Your browser doesn't support javascript.
loading
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆.
Owen, C N; Shoushtari, A N; Chauhan, D; Palmieri, D J; Lee, B; Rohaan, M W; Mangana, J; Atkinson, V; Zaman, F; Young, A; Hoeller, C; Hersey, P; Dummer, R; Khattak, M A; Millward, M; Patel, S P; Haydon, A; Johnson, D B; Lo, S; Blank, C U; Sandhu, S; Carlino, M S; Larkin, J M G; Menzies, A M; Long, G V.
Afiliação
  • Owen CN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Shoushtari AN; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Chauhan D; The Royal Marsden NHS Foundation Trust, London, UK.
  • Palmieri DJ; Westmead Hospital and Blacktown Hospitals, Sydney, Australia.
  • Lee B; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
  • Rohaan MW; Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Mangana J; University Hospital Zurich, Zürich, Switzerland.
  • Atkinson V; Greenslopes Private Hospital, Princess Alexandra Hospital and The University of Queensland, Brisbane, Australia.
  • Zaman F; The Alfred Hospital, Melbourne, Australia.
  • Young A; Vanderbilt University Medical Center, Nashville, USA.
  • Hoeller C; Medical University of Vienna, Vienna, Austria.
  • Hersey P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Dummer R; University Hospital Zurich, Zürich, Switzerland.
  • Khattak MA; Fiona Stanley Hospital, The University of Western Australia, Perth, Australia.
  • Millward M; School of Medicine and Pharmacology, Nedlands, Australia.
  • Patel SP; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Haydon A; The Alfred Hospital, Melbourne, Australia.
  • Johnson DB; Vanderbilt University Medical Center, Nashville, USA.
  • Lo S; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Blank CU; Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Sandhu S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
  • Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Westmead Hospital and Blacktown Hospitals, Sydney, Australia.
  • Larkin JMG; The Royal Marsden NHS Foundation Trust, London, UK.
  • Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia. Electronic address: georgina.long@sydney.edu.au.
Ann Oncol ; 31(8): 1075-1082, 2020 08.
Article em En | MEDLINE | ID: mdl-32387454
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article